Document is current
Any future updates will be listed below
-
Authors
Sydow, Peter
Gmeinwieser, Norbert
Pribbernow, Katrin
Keck, Christoph
Wiegratz, Inka
-
Funding
Funding for this research was provided by:
Teva GmbH Germany (-)
Teva Branded Pharmaceutical Products R&D, Inc., Frazer, PA, USA (-)
Theramex HQ UK Ltd (-)
- License Information
-
More Information
Article History
Received: 2 February 2020
Accepted: 11 May 2020
First Online: 26 May 2020
Ethics approval and consent to participate
: The study was reviewed by the appropriate ethics committees. Patients provided written informed consent prior to study participation.
: Not applicable.
: PS: Received honoraria for consultancy, presentations, and involvement in clinical studies from Teva, Merck, and Ferring.NG: Received personal fees from Pharmalog Institut für klinische Forschung GmbH, subcontracted service CRO of Teva GmbH Germany for this non-interventional study.KP: Received honoraria for consultancy, presentations and involvement in clinical studies from Teva GmbH Germany/Pharmalog Institut für klinische Forschung GmbH.CK: Received honoraria for consultancy and presentations from Teva GmbH Germany, Kade, Gedeon Richter, Exeltis, Merck Serono, Theramex.IW: Received honoraria for consultancy, presentations, and involvement in clinical studies from Teva, Merck, Ferring, Theramex, MSD, Pharmalog.
